Engineers Gate Manager’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-101,062
| Closed | -$952K | – | 2405 |
|
|
2026
Q1 | $952K | Buy |
101,062
+21,408
| +27% | +$235K | 0.01% | 1077 |
|
|
2025
Q4 | $989K | Buy |
+79,654
| New | +$1.06M | 0.01% | 1045 |
|
|
2025
Q3 | – | Sell |
-94,793
| Closed | -$1.16M | – | 2328 |
|
|
2025
Q2 | $1.16M | Buy |
+94,793
| New | +$1.38M | 0.01% | 1038 |
|
|
2025
Q1 | – | Sell |
-23,950
| Closed | -$543K | – | 2341 |
|
|
2024
Q4 | $543K | Sell |
23,950
-169,493
| -88% | -$3.7M | 0.01% | 1369 |
|
|
2024
Q3 | $3.51M | Buy |
193,443
+167,152
| +636% | +$3.87M | 0.07% | 390 |
|
|
2024
Q2 | $766K | Sell |
26,291
-24,572
| -48% | -$729K | 0.02% | 1029 |
|
|
2024
Q1 | $1.8M | Sell |
50,863
-20,670
| -29% | -$827K | 0.05% | 521 |
|
|
2023
Q4 | $3.12M | Buy |
71,533
+7,247
| +11% | +$285K | 0.09% | 310 |
|
|
2023
Q3 | $2.46M | Buy |
64,286
+187
| +0.3% | +$7.87K | 0.09% | 310 |
|
|
2023
Q2 | $2.64M | Buy |
+64,099
| New | +$3.09M | 0.1% | 259 |
|
|
2022
Q4 | – | Sell |
-72,990
| Closed | -$3.09M | – | 1835 |
|
|
2022
Q3 | $3.09M | Buy |
72,990
+33,216
| +84% | +$1.7M | 0.19% | 104 |
|
|
2022
Q2 | $2.15M | Buy |
39,774
+30,906
| +349% | +$1.86M | 0.08% | 332 |
|
|
2022
Q1 | $570K | Buy |
8,868
+3,168
| +56% | +$209K | 0.02% | 995 |
|
|
2021
Q4 | $382K | Sell |
5,700
-10,877
| -66% | -$736K | 0.02% | 1241 |
|
|
2021
Q3 | $1.14M | Sell |
16,577
-6,197
| -27% | -$438K | 0.06% | 433 |
|
|
2021
Q2 | $1.55M | Buy |
+22,774
| New | +$1.61M | 0.1% | 252 |
|
|
2020
Q4 | – | Sell |
-33,188
| Closed | -$1.57M | – | 1818 |
|
|
2020
Q3 | $1.57M | Buy |
33,188
+5,488
| +20% | +$261K | 0.07% | 400 |
|
|
2020
Q2 | $1.3M | Sell |
27,700
-7,081
| -20% | -$348K | 0.07% | 475 |
|
|
2020
Q1 | $1.55M | Buy |
34,781
+26,567
| +323% | +$1.39M | 0.11% | 252 |
|
|
2019
Q4 | $479K | Sell |
8,214
-2,379
| -22% | -$142K | 0.02% | 1007 |
|
|
2019
Q3 | $636K | Buy |
+10,593
| New | +$631K | 0.03% | 687 |
|
|
2019
Q2 | – | Sell |
-6,100
| Closed | -$340K | – | 1247 |
|
|
2019
Q1 | $340K | Sell |
6,100
-51,751
| -89% | -$2.64M | 0.02% | 710 |
|
|
2018
Q4 | $2.61M | Buy |
+57,851
| New | +$3.17M | 0.21% | 146 |
|
|
2018
Q1 | – | Sell |
-40,570
| Closed | -$1.94M | – | 870 |
|
|
2017
Q4 | $1.94M | Buy |
+40,570
| New | +$1.99M | 0.13% | 281 |
|
Other funds holding IART
RCMNY
PCMI
Engineers Gate Manager's IART Position: Q2 2026 in Review
Engineers Gate Manager sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 101,062 shares — an estimated $952K sold.
Engineers Gate Manager first reported a position in IART in Q4 2017 and held it in 24 quarters. The position peaked at $3.51M in Q3 2024. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- Engineers Gate Manager reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
- Engineers Gate Manager sold 101,062 Integra LifeSciences shares in Q2 2026, an estimated $952K.
- Engineers Gate Manager first reported a position in Integra LifeSciences in Q4 2017 and held it in 24 quarters.
- Engineers Gate Manager's Integra LifeSciences position peaked at $3.51M in Q3 2024.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.